A patient with Wegener's granulomatosis in apparent remission presenting with complete atrioventricular block  by Cassidy, Christopher John et al.
Journal of Cardiology Cases (2011) 3, e71—e74
avai lab le at www.sc iencedi rec t .com
journa l homepage: www.e lsev ier .com/ locate / j ccase
Case Report
A patient with Wegener’s granulomatosis in apparent
remission presenting with complete atrioventricular
block
Christopher John Cassidy (MBChB MRCP)a,∗, Evin Sowden (MRCP)b, John
Brockbank (MBChB FRCP)b, Lee-Suan Teh (MD FRCP)b, Emily Ho (MD MRCPI) a
a Department of Cardiology, Royal Blackburn Hospital, Haslingden Road, Blackburn BB2 3HH, United Kingdom
b Department of Rheumatology, Royal Blackburn Hospital, Blackburn, United Kingdom
Received 7 November 2010; received in revised form 16 January 2011; accepted 24 January 2011
KEYWORDS
Wegener’s
granulomatosis;
Complete
atrioventricular
Summary Wegener’s granulomatosis is a systemic necrotizing granulomatous vasculitis of
small- to medium-sized vessels typically affecting upper and lower airways, lungs, and kid-
neys. Cardiac involvement is less common and conducting tissue involvement is extremely rare.
Cardiac manifestations are often not clinically apparent, but are associated with increased mor-
tality. We report the case of a 36-year-old female with Wegener’s thought to be in remission,block;
Cardiac involvement;
Multisystem disorder;
Pacemaker
presenting in complete atrioventricular (AV) block, with echocardiographic evidence of basal
interatrial septum and basal lateral left atrial wall thickening. Despite immunosuppression ther-
apy a permanent pacemaker was required for recurring complete AV block. Although rare, this
case emphasizes the need for careful and regular screening for cardiac involvement in this
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Introduction
Wegener’s granulomatosis is a systemic necrotizing gran-
ulomatous vasculitis of small- to medium-sized vessels
associated with diffuse cytoplasmic anti-neutrophil cyto-
plasmic antibodies (cANCA) speciﬁc for proteinase-3 (PR3).
It typically affects the upper and lower airways, lungs, and
kidneys. Less commonly, cardiac involvement manifests
in 6—25% of unselected patients with Wegener’s granu-
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omatosis, and up to 44% of patients with severe renal
nvolvement, usually as pericarditis, myocarditis, and aor-
itis, although myocardial infarction is also recognized [1].
ardiac conducting tissue involvement is extremely rare.
lthough often not clinically apparent, cardiac involvement
s associated with increased mortality [2]. We report a
ase of complete atrioventricular block in a patient with
egener’s granulomatosis thought to be in remission, and
eview the current literature.ase report
36-year-old woman with a three-month history of pre-
yncopal symptoms presented with two syncopal episodes
Published by Elsevier Ltd. All rights reserved.
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Figure 2 Transthoracic apical 4-chamber view showing
marked thickening of the basal interatrial septum and basal
lateral atrial wall.
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complete AV block did not appear until 1969 [3]. Since then,igure 1 Electrocardiogram showing complete atrioventricu-
ar block.
n May 2010. At the initial presentation her electrocardio-
ram showed sinus rhythm with ﬁrst degree atrioventricular
AV) block and a PR interval of 250ms. Overnight monitoring
id not reveal any other abnormality and she was discharged
ith plans for further outpatient cardiac investigation. Six
ays later she re-presented with a second episode of syn-
ope and at this time electrocardiogram showed complete
V dissociation with a ventricular rate of 28 beats per minute
Fig. 1). No other symptoms or signs of systemic illness were
licited.
In June 2008 she had been diagnosed with Wegener’s
ranulomatosis after presenting with a two-week history
f nasal crusting, loss of hearing, polyarthralgia, and
mall-vessel ischemia of the ﬁngers and toes. At that
ime erythrocyte sedimentation rate (ESR) was 86mm/h,
-reactive protein (CRP) 140mg/l, and cANCA immunoﬂu-
rescence was positive with anti-PR3 titre of 103 units
normal range 0—7units) by enzyme-linked immunosorbent
ssay. An electrocardiogram had been performed showing
inus rhythm with a normal PR interval and QRS duration,
ut regrettably no other cardiac investigation, including
chocardiography, had been undertaken at the time of
rst diagnosis. She was treated with high-dose steroids,
yclophosphamide, prostacyclin, and co-trimoxazole. Clin-
cal and laboratory remission was achieved by September
008, and she was maintained on azathioprine therapy.
At the time of this admission, her inﬂammatory mark-
rs were mildly elevated (ESR of 19mm/h and CRP of
3mg/l) and the anti-PR3 titre was normal (4.5 units). Serum
otassium was increased at 7mmol/l with a creatinine of
18mol/l, without erythrocyturia, urinary casts, or pro-
einuria. Although she initially settled into a sinus rhythm
ith ﬁrst-degree AV block following correction of her hyper-
alaemia, complete AV block recurred the next day despite
ormal electrolyte levels.A transthoracic echocardiogram showed markedly thick-
ned basal segments of her left atrium, including the basal
nteratrial septum (Figs. 2 and 3). Left ventricular chamber
ize and wall thickness were normal, with normal systolic
t
p
s
pigure 3 Transthoracic apical 3-chamber view showing similar
arked thickening of the basal posterior and anterior left atrial
all.
nd diastolic function. It was felt, given the raised inﬂam-
atory markers, that she may have active granulomatous
isease affecting the region of the atrioventricular node
nd she was treated with intravenous methylprednisolone
nd cyclophosphamide. Despite this, she continued to expe-
ience symptomatic high-grade AV block with prolonged
pisodes of ventricular standstill and so a dual chamber
acemaker was implanted.
At three-month follow-up she remained asymptomatic.
owever, her transthoracic echocardiographic appearances
ere essentially unchanged and she had been pacing depen-
ent for 85% of the time in the month up to review.
iscussion
ardiac involvement of Wegeners’s granulomatosis was ﬁrst
eported by Wegener in 1936, but the ﬁrst case of associatedhere have only been 13 cases previously reported in the
ublished literature and all but one case was associated with
ystemic disease (Table 1) [1,3—14]. Complete AV block was
resent at disease onset in 50% and in 70% by one year. Half
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Table 1 Summary of reported cases of complete heart block.
Case Authors Year Age/sex Type Duration (months) Previous
treatment
Treatment Outcome
1 Longauer [3] 1969 47, F syst 0 — cs, ppm died
2 Forstot [1] 1980 26, M syst 11 cs cs, cyc, tpw, ppm resolution
3 Krulder [5] 1985 46, M syst 12 — cs, cyc, ppm resolution
4 Schiavone [6] 1985 43, M syst 7 — cs, cyc resolution
5 Handa [7] 1997 35, M syst 0 — cs, cyc, tpw resolution
6 Ohkawa [4] 1999 61, F syst 0 — cs died
7 Khurana [8] 2000 47, F syst 1 — cs, cyc resolution
8 Suleymenlar [9] 2002 27, F syst 13 cs, cyc cs, cyc, tpw resolution
9 Wilcke [10] 2003 63, M syst 0.3 — cs, cyc, pph, tpw resolution
10 Ghaussy [11] 2004 36, M lim >12 — — resolution
11 Elikowski [12] 2006 52, M syst 14 cs, cyc, cic cs, cyc, tpw, ppm unknown
12 Lim [13] 2007 61, M syst 2 — cs, cyc resolution
ic; c
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R13 Sarlon [14] 2010 77, M syst 0
Abbreviations used: F, female; M, male; lim, limited; syst, system
azathioprine; ppm, permanent pacemaker; tpw, temporary pacing
the cases were asymptomatic, although all had clinical or
laboratory evidence of active disease.
Echocardiograms were performed in nine of the patients
and abnormalities were present in six; most commonly
valvular abnormalities and pericardial effusion. This is in
keeping with a review of echocardiography in 85 patients
with conﬁrmed Wegener’s granulomatosis ﬁnding abnor-
malities in 86% [2]. Treatment included corticosteroids,
cyclophosphamide, temporary pacing wire, and pacemaker
implantation. The complete AV block resolved in 9 of the
13 cases. Two patients died of cardiac dysrhythmia, neither
of which had been treated with cyclophosphamide. Post-
mortem examination of the ﬁrst case reported by Longauer
et al. showed granulomatous involvement of the conduction
system with ﬁbrosis and hyalinization, but not necrosis [3].
In the second case, Ohkawa et al. reported small foci of
inﬂammation affecting the sinus and AV nodes with AV nodal
arteritis, inﬂammatory necrotising granulomatous involve-
ment of the conducting system, and myocardium associated
with an exudative endocarditis and ﬁbrinous pericarditis [4].
Compared to previously published cases, our patient was
unusual in that she had relatively longer disease duration
of 24 months at diagnosis, she had previously been treated
with intravenous cyclophosphamide, and she had no clinical
or laboratory evidence of extra-cardiac increased disease
activity. Although a low level cANCA level was detected in
our patient, this would be considered as normal according
to local reference values. The signiﬁcance of this is unclear
as some Wegner’s patients experience persistent detectabil-
ity of cANCA without adverse outcome, whilst up to 20%
of patients with limited active disease may have negative
levels [15,16]. Given this uncertainty, we opted to treat
her with further immunosuppression on the basis of raised
inﬂammatory markers and cardiac imaging suspicious for
granulomatous involvement. However, it is certainly possible
that her echocardiographic appearances represented ﬁbro-
sis rather than active granulomatous disease. The unchanged
appearance at follow up may support the latter possibility.
On the transthoracic images presented the obvious thick-
ening is of the atrial walls which would not in itself lead— cs, cyc, ppm died
s, corticosteroids; cyc, cyclophosphamide; cic, ciclosporin; aza,
.
o complete AV block, however, she is young and otherwise
ell and so we would feel that an association between these
bnormalities and her presentation is likely. We had hoped
o arrange magnetic resonance imaging to try and clarify if
isease was also present at the AV node and His conducting
issue, but her need for pacing support prevented this.
In summary, complete AV block is a rare but treatable
anifestation of cardiac involvement usually associated
ith early active systemic disease. All patients diagnosed
ith Wegener’s granulomatosis should be screened with a
aseline electrocardiogram and a transthoracic echocardio-
ram to document cardiac involvement and alert clinicians
o those at risk of further cardiac complications. Echocardio-
raphy frequently detects abnormalities suggesting cardiac
nvolvement in asymptomatic individuals and this case high-
ights that later presentation of cardiac abnormalities than
reviously reported can occur and lifelong surveillance
eeds to be considered given the poorer prognosis in these
ndividuals. In turn, all patients presenting with cardiac
bnormalities and evidence of systemic inﬂammation should
e screened for Wegener’s by clinical, laboratory, and radio-
raphic assessment.
eferences
[1] Forstot JZ, Overlie PA, Neufeld GK, Harmon CE, Forstot SL. Car-
diac complications of Wegener granulomatosis: a case report
of complete heart block and review of the literature. Semin
Arthritis Rheum 1980;10:148—54.
[2] Oliveira GH, Seward JB, Tsang TS, Sprecks U. Echocardiographic
ﬁndings in patients with Wegener granulomatosis. Mayo Clin
Proc 2005;80:1435—40.
[3] Longauer F, Takac M, Halasova K. On damage of the heart con-
duction system in Wegener’s granulomatosis. Z Kreislaufforsch
1969;58:412—21.
[4] Ohkawa S, Miyao M, Chida K, Mizuuchi T, Kida K, Takubo K,
Ohtsubo K. Extensive involvement of the myocardium and the
cardiac conduction system in a case of Wegener’s granulomato-
sis. Jpn Heart J 1999;40:509—15.
[5] Krulder JW, Niermeijer P. Reversible atrioventricular block due
to Wegener’s granulomatosis. Neth J Med 1985;28:28—31.
e[
[
[
[
[
[
[74
[6] Schiavone WA, Ahmad M, Ockner SA. Unusual cardiac
complications of Wegener’s granulomatosis. Chest 1985;88:
745—8.
[7] Handa R, Wali JP, Aggarwal P, Wig N, Biswas A, Kumar AK.
Wegener’s granulomatosis with complete heart block. Clin Exp
Rheumatol 1997;15:97—9.
[8] Khurana C, Mazzone P, Mandell B. New onset left bun-
dle branch block with right axis deviation in a patient
with Wegener’s granulomatosis. J Electrocardiol 2000;33:
199—201.
[9] Suleymenlar G, Sarikaya M, Sari R, Tuncer M, Sevinc A.
Complete heart block in a patient with Wegener’s granu-
lomatosis in remission—–a case report. Angiology 2002;53:
337—40.
10] Wilcke JT, Nielsen PK, Jacobsen TN. Reversible complete
heart block due to Wegener’s granulomatosis. Int J Cardiol
2003;89:297—8.
11] Ghaussy NO, Du Clos TW, Ashley PA. Limited Wegener’s gran-
ulomatosis presenting with complete heart block. Scand J
Rheumatol 2004;33:115—8.C.J. Cassidy et al.
12] Elikowski W, Baszko A, Puszczewicz M, Stachura E. Complete
heart block due to Wegener’s granulomatosis: a case report and
literature review. Kardiol Pol 2006;64:622—7.
13] Lim HE, Lee YH, Ahn JC. Wegener’s granulomatosis with pro-
gressive conduction disturbances and atrial ﬁbrillation. Heart
2007;93:77.
14] Sarlon G, Durant C, Grandgeorge Y, Bernit E, Veit V, Hamidou M,
Schleinitz N, Harlé JR. Cardiac involvement in Wegener’s gran-
ulomatosis: report of four cases and review of the literature.
Rev Med Interne 2010;31:135—9 [in French].
15] Witko-Sarsat V, Reuter N, Mouthon L. Interaction of proteinase
3 with its associated partners: implications in the patho-
genesis of Wegener’s granulomatosis. Curr Opin Rheumatol
2010;22:1—7.
16] Finkielman JD, Lee AS, Hummel AM, Viss MA, Jacob GL, Hom-
burger HA, Peikert T, Hoffman GS, Merkel PA, Spiera R, St
Clair EW, Davis Jr JC, McCune WJ, Tibbs AK, Ytterberg SR,
et al. ANCA are detectable in nearly all patients with active
severe Wegener’s granulomatosis. Am J Med 2007;120, 643.
e9—14.
